Eric Brandt - May 2, 2023 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
Director
Signature
/s/ Dane Baumgardner, Attorney-In-Fact for Eric K. Brandt
Stock symbol
XRAY
Transactions as of
May 2, 2023
Transactions value $
-$4,340
Form type
4
Date filed
5/3/2023, 04:41 PM
Previous filing
Apr 18, 2023
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Options Exercise $257K +6.2K +13.81% $41.47 51.1K May 2, 2023 Direct
transaction XRAY Common Stock Sale -$261K -6.2K -12.13% $42.17 44.9K May 2, 2023 Direct F1
holding XRAY Common Stock 5.4K May 2, 2023 By The Brandt Family Trust U/a Dtd 06/09/2006

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Options Exercise $0 -6.2K -100% $0.00* 0 May 2, 2023 Common Stock 6.2K $41.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2021, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 This option is fully vested and exercisable.